Ozop Surgical Corp. Announces Successful Up-Listin
Post# of 107
(Total Views: 159)
Posted On: 02/24/2019 11:50:40 AM
Ozop Surgical Corp. Announces Successful Up-Listing Approval to OTCQB Marketplace
OZSC now trades on the OTCQB
WEST PALM BEACH, Fla., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Ozop Surgical Corp. (OTCQB: OZSC), announces that effective today it now trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Click here to see interview with Michael Chermak, CEO of Ozop, https://www.youtube.com/embed/-BDs9I_I8Ac. To qualify for the listing, companies must be current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com/stock/OZSC/quote.
“Our Company is committed to the high level of financial and corporate disclosure that is required for this listing category, which demonstrates our continued commitment to our shareholders. We believe that trading on the OTCQB and being DTC eligible will raise the visibility of the Company, enhance trading liquidity, and broaden our shareholder base as we move forward with market acceptance and penetration of our products and services,” stated Michael Chermak, CEO of Ozop.
“These milestones open the door to institutional investors and market makers who were not previously able to buy and sell shares of our Company. Now they may execute on unsolicited orders and also make recommendations to clients as they so choose. Meeting the increased compliance and information requirements of OTCQB provides our investors greater confidence in the information disclosed by the Company and ensures our commitment to accountability and transparency.”
In 2014, OTC Markets Group introduced standards and eligibility requirements for OTCQB with the goal of making it a better venture marketplace. To be eligible, companies must be current in their reporting to a U.S. or foreign regulator, pass a minimum bid price test of one penny ($0.01), maintain a public float above 5% of total shares issued and outstanding and a market value of public float of at least $2 million and undergo an annual verification and management certification process providing additional information about the company’s insiders, advisors and share count, among other things. Companies that are approved to trade on OTCQB receive access to additional premium services to help them build visibility and improve transparency for investors.
About Ozop Surgical Corp.Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops, manufactures and globally distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers. For more information please visit www.ozopsurgical.com.
Safe Harbor Statement
This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results) and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as "may," "should," "expect," "anticipate," "believe," "estimate," "intend," "plan" and other similar expressions. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Investor Relations:
Ted Haberfield
President
MZ Group - MZ North America
(760) 755-2716
thaberfield@mzgroup.us
www.mzgroup.us
Source: Ozop Surgical Corp.
OZSC now trades on the OTCQB
WEST PALM BEACH, Fla., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Ozop Surgical Corp. (OTCQB: OZSC), announces that effective today it now trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Click here to see interview with Michael Chermak, CEO of Ozop, https://www.youtube.com/embed/-BDs9I_I8Ac. To qualify for the listing, companies must be current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com/stock/OZSC/quote.
“Our Company is committed to the high level of financial and corporate disclosure that is required for this listing category, which demonstrates our continued commitment to our shareholders. We believe that trading on the OTCQB and being DTC eligible will raise the visibility of the Company, enhance trading liquidity, and broaden our shareholder base as we move forward with market acceptance and penetration of our products and services,” stated Michael Chermak, CEO of Ozop.
“These milestones open the door to institutional investors and market makers who were not previously able to buy and sell shares of our Company. Now they may execute on unsolicited orders and also make recommendations to clients as they so choose. Meeting the increased compliance and information requirements of OTCQB provides our investors greater confidence in the information disclosed by the Company and ensures our commitment to accountability and transparency.”
In 2014, OTC Markets Group introduced standards and eligibility requirements for OTCQB with the goal of making it a better venture marketplace. To be eligible, companies must be current in their reporting to a U.S. or foreign regulator, pass a minimum bid price test of one penny ($0.01), maintain a public float above 5% of total shares issued and outstanding and a market value of public float of at least $2 million and undergo an annual verification and management certification process providing additional information about the company’s insiders, advisors and share count, among other things. Companies that are approved to trade on OTCQB receive access to additional premium services to help them build visibility and improve transparency for investors.
About Ozop Surgical Corp.Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops, manufactures and globally distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers. For more information please visit www.ozopsurgical.com.
Safe Harbor Statement
This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results) and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as "may," "should," "expect," "anticipate," "believe," "estimate," "intend," "plan" and other similar expressions. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Investor Relations:
Ted Haberfield
President
MZ Group - MZ North America
(760) 755-2716
thaberfield@mzgroup.us
www.mzgroup.us
Source: Ozop Surgical Corp.
(0)
(0)Ozop Surgical Corp. (OZSC) Stock Research Links
Scroll down for more posts ▼